Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Immunologic Tests × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Paraneoplastic Syndromes 1 Autoimmune Diseases of the Nervous System 1

Interventions

Cyclophosphamide 2055 Radiotherapy 1971 Cisplatin 1837 Carboplatin 1551 Gemcitabine 1443 Paclitaxel 1315 Bevacizumab 1306 pembrolizumab 1231 Docetaxel 1224 Oxaliplatin 1172 Capecitabine 1164 Fluorouracil 1078 Dexamethasone 975 Magnetic Resonance Spectroscopy 952 Nivolumab 932 Rituximab 923 Drug Therapy 899 Surveys and Questionnaires 891 Doxorubicin 844 Etoposide 839 Radiosurgery 808 Blood Specimen Collection 806 Irinotecan 782 Cytarabine 739 fludarabine 710 Leucovorin 679 Surgical Procedures, Operative 632 Lenalidomide 616 Biopsy 582 fludarabine phosphate 565

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05645185 2022-12-09

CarMa2

Hospices Civils de Lyon

Paraneoplastic Syndromes, Autoimmune Diseases of the Nervous System

Data powered by HemOnc (CC BY 4.0) Colophon ⚡